THE DEFINITIVE GUIDE TO PRL-8-53

Specific nations around the world consist of a "substantially related" catch-all clause of their drug regulation, which include New Zealand and Australia. This consists of 6-APB because it is comparable in chemical construction to The category A drug MDA, that means 6-APB may be considered as being a managed substance analogue in these jurisdiction